Document is current
Any future updates will be listed below
-
Authors
Rhodin, Kristen E.
O’Connor, Margaret H.
Therien, Aaron
Hollander, Shayna
Geron, Viviana
Nair, Uma
Rakestraw, Emily
Salama, April K.
Shah, Riddhishkumar
Tyler, Douglas S.
Beasley, Georgia M.
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 25 December 2024
First Online: 27 March 2025
Disclosures
: April Salama: Research funding (paid to institution): Ascentage, Bristol Myers Squibb, Ideaya, Immunocore, Merck, Olatec Therapeutics, Regeneron, Replimune, Seagen, Consultant or advisory role: Bristol Myers Squibb, Iovance, Regeneron, Novartis, Pfizer, Georgia Beasley. Clinical trial funding paid to Duke University from Delcath, Istari, Replimune, Oncosec, Checkmate; one-time advisory board for BMS.
